Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer

By Bernsdorf Mogens   Balslev Eva   Lykkesfeldt Anne   Kroman Niels   Harder Eva   Maase Hans   Jakobsen Erik   Grabau Dorthe   Ejlertsen Bent  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 165-170

Springer Publishing Company

Access to resources Recommend Favorite

Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

By Bernsdorf Mogens  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 463-470

Springer Publishing Company

Access to resources Recommend Favorite

Hormone therapy and estrogen receptor expression in breast cancer

By Friman E. Isaksson   Mahlman M.   Nilsson B.   Skoog L.   Löfgren L.   Wilking N.   Von Schoultz E.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 194-198

Informa Healthcare

Access to resources Recommend Favorite

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation

By Antalis Caryl   Arnold Tyler   Rasool Tamkeen   Lee Bonggi   Buhman Kimberly   Siddiqui Rafat  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 661-670

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen receptor and breast cancer

By Sommer S.   Fuqua S.A.W.  

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 339-352

Academic Press

Access to resources Recommend Favorite